| Name | Title | Contact Details |
|---|---|---|
Lars Boesgaard |
Chief Financial Officer | Profile |
Seth Van Voorhees |
Chief Financial Officer | Profile |
Matthew Hill |
Chief Financial Officer | Profile |
CTMG is a Greenville, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At Cradle Genomics, our mission is to provide knowledge that helps every pregnancy.
Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity.
Makindus is a privately-held, specialty pharmaceutical development company focused on ophthalmology and rare diseases. The Company`s lead product candidate is MI-100, a novel ophthalmic formulation of a legacy compound being developed for Stargardt disease, a rare form of juvenile macular degeneration that occurs in approximately 1 in 10,000 individuals. Makindus has met with the FDA and EMA, and is in the final stages of planning a Phase 3 clinical trial program. The Company is seeking partners and additional sources of funding and collaboration for the development program of MI-100 for Stargardt disease.
The most innovative, patient and provider focused preventative diagnostic laboratory in the industry